T. Rowe Price Health Care ETF (TMED)
| Assets | $19.35M |
| Expense Ratio | 0.44% |
| PE Ratio | 25.12 |
| Shares Out | 650,000 |
| Dividend (ttm) | $0.16 |
| Dividend Yield | 0.55% |
| Ex-Dividend Date | Dec 23, 2025 |
| Payout Ratio | 13.63% |
| 1-Year Return | n/a |
| Volume | 1,871 |
| Open | 29.80 |
| Previous Close | 29.63 |
| Day's Range | 29.56 - 29.80 |
| 52-Week Low | 23.46 |
| 52-Week High | 31.19 |
| Beta | n/a |
| Holdings | 107 |
| Inception Date | Jun 11, 2025 |
About TMED
Fund Home PageThe T. Rowe Price Health Care ETF (TMED) is an exchange-traded fund. The ETF currently has 19.82m in AUM and 101 holdings. TMED is an actively managed ETF, aiming to outperform its respective sector index TMED was launched on Jun 11, 2025 and is issued by T. Rowe Price.
Top 10 Holdings
44.68% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 14.35% |
| UnitedHealth Group Incorporated | UNH | 7.90% |
| Gilead Sciences, Inc. | GILD | 4.47% |
| Thermo Fisher Scientific Inc. | TMO | 4.20% |
| Abbott Laboratories | ABT | 3.68% |
| Danaher Corporation | DHR | 2.55% |
| Stryker Corporation | SYK | 2.10% |
| West Pharmaceutical Services, Inc. | WST | 1.83% |
| Boston Scientific Corporation | BSX | 1.81% |
| Dyne Therapeutics, Inc. | DYN | 1.79% |
News
Eyeing Healthcare Stocks? TMED Is Smashing Its Benchmark
In an uncertain marketplace, where are investors to go? Sector funds could provide one intriguing set of tools to consider.
T. Rowe Price Expands ETF Lineup With 3 Actively Managed Sector Picks Across Key Sectors
In a world where passive investing tends to dominate the headlines, T. Rowe Price is gambling on an alternative formula: sector-focused active management, and at lower costs.
T. ROWE PRICE ADDS THREE NEW TRANSPARENT SECTOR OFFERINGS TO ITS ACTIVE ETF ROSTER
BALTIMORE, June 12, 2025 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm, announced today the addition of three new active transparent equity exchange-traded funds...